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INTRODUCTION 
“The papanicolaou staining technique is a polychromatic staining 
method elaborated by   George N Papanicolaou, who is considered to be 
the father of cytology in 1942 and further developed  by him in 1954 and 
in 1960”. 
Pap stain is used to differentiate the cells in smear preparations of 
various body fluids, gynecological smears and fine needle aspiration 
material from various organs. 
There has been a lot of controversy as to whether wet-fixed smears 
stained with Papanicolaou stain or air-dried smears stained with 
Romanowsky’s stain are better. In fact, both are complementary, but Pap 
staining permit better assessment of nuclear features and are preferred by 
many histopathologists. 
Quick diagnosis of FNAC plays an important role in efficient 
medical practice. The need for minimal turnaround time for assessing 
FNA smears has encouraged innovations in staining technique that 
require lesser staining time with unequivocal cell morphology. 
Few rapid stains available these days include MGG stain, Diff 
quick stain and toluidine blue stain. However many cytopathologists 
prefer the transparent, traditional, crisp nuclear features offered by 95% 
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ethanol fixed PAP stain rather than air dried smears stained by 
Romanowsky stain. 
To overcome this, ultrafast papanicolaou stain was introduced by 
yang and Alvarez in 1994 which is a hybrid of romanowsky stain and pap 
stain. 
It not only reduces the time for pap stain to 90 seconds, but also 
enhances the quality. Pap stain requires ethanol for fixation. Ethanol is 
expensive and laboratory needs a license for acquiring ethanol in bulk 
quantity. 
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AIM AND OBJECTIVES 
AIM: 
Aim of our study is to assess the use of modified ultra-fast pap 
stain in fine needle aspiration cytology of various organs in comparison 
with the standard conventional pap stain and MGG stain. 
OBJECTIVES: 
To compare the results of MUFP, Routine pap and May Grunwald 
Giesma (MGG) stain”. 
 To assess the quality of MUFP stain and to find the advantages of 
the same over routine stains used in cytology. 
 To find a cost-effective method which can be adopted in our 
laboratory. 
 To compare the quality of staining procedures used on air dried 
smears (MGG and MUFP) over the wet fixed smears (Pap stain) 
 To assess the utility and applicability of these stains in 
cytomorphological study in FNAC of thyroid, breast, and lymph 
nodes. 
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REVIEW OF LITERATURE 
Cytology started as a revolutionary idea of looking at imprints of 
cut surface of tumors at postmortem. It has evolved through many new 
methods of procuring, fixing and staining cells. Its main attribute lies in 
its ability to allow prompt, accurate assessment of cell changes on 
material taken with minimally invasive procedure and processing.
1 
The evolution of cytopathology occurred through four overlapping 
eras; 
a) 1860-1940:  Early history.  
b) 1860-1940:  Development and expansion of exfoliative cytology in 
the USA and elsewhere. 
c) 1955-1985:  Consolidation of cytopathology as a discipline and the 
parallel developments of population screening and FNA cytology.  
d) 1955-1985: Maturation of cytopathology as a discipline and its 
integration with new technology (1985 to the present day).
1
 
In the early historical era microscopic observations of normal and 
abnormal human cells either in exfoliated or in imprints or scrapes were 
steadily and independently recorded throughout the nineteenth century.
2,3
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By  first decade of twentieth century, exfoliative cancer cells had been 
described in all types of specimens.
4
 
In 1922, professor LS Dudgeon used cytology at St. Thomas 
Hospital for the diagnosis of a wide variety of neoplastic and 
inflammatory diseases from imprints of surgical specimens.
5
 Dudgeon 
considered that the stained films were much nicer to examine than 
paraffin sections.
6
 At the same time in USA, FNA cytology was 
developing and the first series on aspiration of neoplasms was published 
from memorial Hospital for cancer and allied diseases in New York City.
7 
A second era of cytopathology began in 1941 with the publication 
of “The diagnostic value of vaginal smears in carcinoma of uterus” by 
George N. Papanicolaou, an anatomist, and Herbert F. Traut, a 
gynaecologist.
8 Papanicolaou’ contribution to this field was two-fold; he 
recognized the importance of wet fixation of cytological specimens and 
he systematically began to accumulate examples of cancer cells in vaginal 
smears, culminating in his paper New Cancer Diagnosis.
9 
Concurrently with the development of cervical screening the 
cytological method of cancer diagnosis began to be more widely applied 
to the respiratory, alimentary and urinary tracts as well as to the serous 
cavities and the central nervous system.
1
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The era of consolidation was heralded by two publications: the first 
issue of Acta cytologica in 1957 - the oldest journal devoted exclusively 
to cytopathology; and in 1961 - by the publication of “Diagnostic 
cytology and its Histopathologic bases by Leopold G.Koss in association 
with Grace R. Durfe”.10 
In the last 60 years there is an explosion in the literature of 
cytopathology, with thousands of articles and scores of books written on 
the subject.
1
 
Population based cervical screening is now practiced to a greater or 
lesser extent in almost all countries of the developed world.
1 
The imperial 
cancer Research Fund Coordinating Committee on cervical screening 
made the statement in 1984 that ‘with the exception of non smoking, 
cervical cytology screening offers the only major proved public health 
measure for significantly reducing the burden of disease,
11
 its 
introduction was highly controversial and has remained so at every stage 
of its development. 
By 1986, there was sufficient evidence from an international 
multicentre analysis to show that 5 yearly and 3-yearly screening reduced 
the risk of invasive cancer by 84% and 93% respectively, while little 
additional benefit was achieved by annual screening.
12 
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The impetus of the development of cytopathology as we know it 
today resulted from the painstaking research of papanicolaou in the USA. 
Thus papanicolaou is justly referred to as the ‘Father of cytopathology’.13 
PAPANICOLAOU STAIN 
For the routine diagnostic cytology, the papanicolaou stain is 
recommended. 
The use of the papanicolaou stain results in well-stained nuclear 
chromatin, differential cytoplasmic counterstaining, and cytoplasmic 
transparency.
14
Although, originally developed for interpretation for 
gynaecological specimen, Papanicolaou staining is now commonly used 
to facilitate the accurate detection and interpretation of abnormal cells 
from variety of sources. 
NUCLEAR STAINS
15
: 
Haematoxylin: 
Haematoxylin - most widely used nuclear stain. It is extracted from 
logwood  campeachy wood). The Haematoxylin campechianum is a tree 
that has been scientifically cultivated in Jamaica since 1715. 
Freshly cut wood is colorless. It becomes dark reddish-brown when 
exposed to atmospheric oxygen.  Haematoxylin is not a dye, only the 
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oxidation product of   hematoxylin-hematein is a weak anionic dye. 
Oxidation of hematoxylin achieved naturally by exposing the solutions to 
atmospheric oxygen or by using oxidizing agents such as sodium iodate, 
mercuric oxide, and potassium permanganate.  Oxidation process is 
called “ripening.” Solutions should always contain some unoxidized 
hematoxylin, since complete or over oxidation leads to a breakdown of 
the solution and the loss of good staining. 
Oxidized hematoxylin (hematein) has little affinity for tissue but 
becomes a strong dye with a particular affinity for nuclei when combined 
with a metallic mordant. 
In some solutions of hematoxylin, the oxidizer also serves as the 
mordant. For (e.g);iron hematoxylin,but it is not stable.  
To achieve stability, the mordant should not oxidize the solution. 
Ammonium or potassium aluminum sulfate, phosphotungstic acid, and 
phosphomolybdic acid are   mordants. “The mordant-dye combination is 
called lake”. most commonly used hematoxylin lakes are combinations of 
hematein with either aluminum or iron. 
The routine nuclear stains should be called aluminum 
hematoxylins, or more properly aluminum hemateins, since aluminium is 
a mordant. 
9 
 
More selective nuclear staining achieved by adding either an 
excess of  acid or an excess of aluminum. 
Formulas for some of the aluminum hematoxylins follow, 
Harris’ Hematoxylin 
Hematoxylin….. 5.0 g 
Absolute ethyl alcohol….. 50.0 ml 
Ammonium aluminium sulfate….. 100.0 g 
Distilled water….. 1000.0 ml 
Mercuric oxide….. 2.5 g 
Gill’s hematoxylin (Gill et al. 1974 modified) 
Preparation of solution 
Hematoxylin 2 g  
Sodium iodate 0.2 g 
Aluminum sulfate 17.6 g 
Distilled water 750 ml 
Ethylene glycol (ethandiol) 250 ml 
Glacial acetic acid 20 ml 
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Ehrlich’s Hematoxylin 
Hematoxylin….. 2gm 
95% Alcohol….. 100ml 
Distilled water….. 100ml 
Glycerol….. 100ml 
Ammonium or Potassium Aluminium sulphate….. 3gm 
Glacial acetic acid….. 10m 
It is used as progressive or Regressive staining. In progressive 
staining the reaction is stopped once the desired staining intensity is 
achieved. In Regressive staining, longer time is required to over stain the 
tissue before the stain is selectively removed in acid alcohol (1% 
hydrochloric acid in 70% ethanol). 
CYTOPLASMIC STAINS
15
: 
 Counterstain is mostly used as eosin.  The staining of eosin is best 
at a pH of 4.6 to 5.0. 
11 
 
Used properly, three shades of pink can be obtained with eosin 
alone; erythrocytes, collagen, and the cytoplasm of muscle or epithelial 
cells should stain with different shades or intensities of pink. 
Eosin solution 
Eosin Y (1% aqueous solution)….. 200.0 ml 
95% ethyl alcohol….. 600.0 ml 
Acetic acid, glacial….. 4.0ml 
2.Eosin-Phloxine B 
Eosin Y (1% aqueous solution)…….. 100.0 ml 
Phloxine B (1% aqueous solution)……. 10.0 ml 
95% alcohol…………….. 780.0 ml 
Acetic acid, glacial….. 5.0ml 
There are multiple acid dyes also used to provide differential 
counterstaining and Cytoplasmic transparency. 
- Orange G6 (OG 6). 
- Eosin azure 36 (EA 36 or EA 50) -contains light green, Eosin 
and bismark brown. 
12 
 
MODIFICATION OF PAPANICOLAOU STAIN
14 
: 
Modification of the original papanicolaou stain (1942) was 
published by  Dr.Papanicolaou in 1954 and 1960.   
Papanicolaou Technique I: Uses Harris hematoxylin regressively. 
Papanicolaou Technique II:  Described for urinary and gastric 
preparations,uses hematoxylin progressively . Other modifications 
include Gill’s modification, Miller’s modification, Saccomanno’s 
modification for carbowax fixed smears and Durfee’s modification for 
urine sediment smears. 
FIXATIVES
14
: 
Rapid fixation of smears is needed to preserve cytological details 
of cells. For many years the fixative of choice for gynecologic and other 
smear preparations was the one recommended by Papanicolaou, a 
solution contain  equal parts of   ether and 95% of ethyl alcohol. 
Subsequently, it is was abandoned, since the ether present in the pap stain 
is a fire hazard.  Ninety-five percent ethyl alcohol (ethanol) is now used 
as a fixative by many laboratories, with excellent results. Smears should 
remain in 95% ethanol fixative for a minimum of 15 minutes prior to 
staining. 
To obtain ethanol without federal taxation, a license is required.  
13 
 
EQUIVALENT CONCENTRATIONS OF SEVERAL ALCOHOLS 
FOR PURPOSES OF CELL FIXATION 
 
100% Methanol 
95% Ethanol 
95% Denatured alcohol 
80%propanol 
80%Isopropanol 
 
WET FIXATION
14,16 
: 
Wet fixation is traditional method of fixation in which smears are 
immediately kept in fixative before air-drying of smears. The 
disadvantages of wet fixed smears are air-drying artifacts, hemorrhagic 
background and cell loss during fixation. 
To overcome these disadvantages, in 1988, Chan and Kung 
reported that air-dried smears can be rehydrated by immersing the smears 
in 0.9% Nacl for 30sec which is used in MUFP. 
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FINE NEEDLE ASPIRATION CYTOLOGY: 
FNA was first introduced in Sweden by Franzen, a haematologist 
& oncologist – tried the Romanowsky staining methods for cytology.17 
The technique was further developed by Soderstrom, Fox and also 
by Lopes Cardoso, Von Haam, Crepinko and Hauptmann.
18 
In  the UK, FNA was pioneered by a surgeon, John webb, who was 
given enthusiastic support by some of the renowed cytopathologists of the 
time.
19
 The technique also became popular in the USA after a long 
interval since its early use in the 1930s. 
The present day focus of FNA cytology is on obtaining a 
satisfactory specimen on which a reliable diagnosis can be made and 
therefore, that the aspirate sample should provide   true reflection of the 
disease process.
20 
FNA is now established as the first line investigation of 
mass lesions where-ever they occur in the body.
20
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ADVANTAGES OF FNA
 20
 : 
It is a minimally invasive procedure. 
The technique is relatively painless, produces a quick result and is 
economical. 
The method is applicable to easily palpable lesions.  
New radiological techniques are now available for internal imaging 
of organs and also for FNA of deep seated impalpable structures. 
It can be done as OP procedure, so hospital stay can be avoided. 
Diagnosis can be obtained within minutes rather than days 
Mostly accurate in many situation, hence it is used as essential 
preoperative /pretreatment investigation 
Risk of complication will be less is an additional advantage that 
allows FNA cytology to be performed as an OP procedure. 
Cells obtained by FNA can be manipulated in a variety of ways 
useful for ultra structural study, Immunocytochemistry, gene 
rearrangement, morphometry,  image analysis and DNA analysis. 
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In routine practice, success of FNAC depends on 
1. Samples from the representative lesion. 
2. Adequate number of cells and other tissue components. 
3. Smear making and processing of the samples. 
4. Accompanied by correct clinical /radiological information. 
LIMITATIONS OF FNAC  
“FNA cytology has its own limitations. Scanty samples and loss of 
histological architecture leads to difficulty in interpretation of FNA 
smears based on morphology. 
 There is a risk of complications of FNA. The overall morbidity 
and mortality to FNA has been estimated in several studies and the risk of 
death is approximately 1 in 1500. 
Serious complications have been reported such as major 
hemorrhage after FNA of lung, liver and kidney; septicemia after prostate 
aspiration; bile peritonitis following needling of liver; and acute 
peritonitis resulting from pancreatic aspiration. However, such 
complications are very rare. Review of literature shows, the risk is 
increased due to multiple passes, larger needles, and absence of normal 
parenchyma covering the lesion .
20
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Contraindications of deep seated aspiration- It include 
anticoagulant therapy and Intrinsic bleeding problems because it produce 
increase the risk of bruising and hemorrhage. 
Intractable cough and poor respiratory function are absolute 
contraindications to transthoracic FNA. 
Aspirates of unsuspected hydatid cyst carry the potential risk of 
anaphylactic shock resulting from rupture and is best avoided. 
FNA of phaeochromocytomas is contraindicated for fear of 
inducing a hypertensive crisis.
20 
NEED FOR RAPID ASSESSMENT IN CYTOLOGY: 
Quick diagnosis of fine-needle aspiration cytology (FNAC) plays 
an important role in efficient medical practice.
22
 Rapid assessment of 
FNA smears has become increasingly popular due to the global trend in 
reducing health care costs. 
The goal is minimal time for hospitalization and the fastest 
possible turnaround time for test results.
23 
Immediate examination of the aspirates for adequacy, while the 
patient remains in the biopsy suite, reduces the number of inadequate 
samples and decreases the number of needle passes performed.
24 
18 
 
The need for minimal turnaround time for assessing fine needle 
aspiration smears has encouraged innovations in staining technique that 
require lesser staining time with unequivocal cell morphology.
25 
TWO FUNDAMENTALLY DIFFERENT METHODS ARE USED 
FOR ROUTINE FIXATION AND STAINING OF CYTOLOGIC 
SPECIMENS. 
Romanowsky-type stains (e.g., Wright’s, May- Grunwald Giemsa, 
Diff-Quick) are based on air-drying.
26 
 
The trichrome papanicolaou and bichrome Hematoxylin and Eosin 
are based on wet-fixation.
 
Many cytopathologists prefer the transparent traditional, crisp 
nuclear features offered by 95%, ethanol fixed papanicolaou stain than 
nuclear features (opacity of nuclei, nuclear enlargement etc.) offered by 
air-dried Romanowsky stains.
25
 
MODIFIED ULTRAFAST PAPANICOLAOU STAIN (MUFP): 
To overcome the disadvantages of both Romanowsky and pap 
stains, Yang and Alverez in 1995 suggested an ultrafast Papanicolaou 
(UFP) stain, which is a hybrid of Romonwsky and Pap stains, and 
requires only 90 seconds. 
19 
 
It involves rehydration of air dried smears, fixation in alcoholic 
formalin and subsequent pap staining except that the duration of each step 
is shortened.
25
 
ULTRAFAST PAPANICOLAOU STAIN
23
 
1. Normal saline   -    30 seconds 
2. 95% Ethanol (optional), for storage/transport 
3. Alcoholic formalin -    10 seconds 
4. Water   -     6 slow dips  
5. Richard –Allan Hematoxylin 2    2 slow dips 
6. Water   -     6 slow dips 
7. 95% Ethanol     - 6 slow dips 
8. Richard-Allan Cytostain    - 4 slow dips 
9. 95% Ethanol   -    6 slow dips 
10. 100% Ethanol   -    6 slow dips 
11. Xylene   -    10 slow dips 
12. Mount and coverslip 
20 
 
Earlier rapid papanicolaou stains (Kline’s rapid and Tao’s rapid) 
are identical to the routine stain except that the duration of each step is 
shortened. 
The problem with rapid papanicolaou stain is four fold: 
1. Both the cytoplasm and nucleus lose much cellular detail from 
inadequate fixation.  
2. Since FNA samples are inherently bloody, the tumor cells are often 
covered with ubiquitous RBC’s, this is particularly annoying with 
papanicolaou stain as RBC’s stain orange. 
3. The wet-fixed cells are much smaller than air-dried cells; 
4. Loss of wet fixed cells during processing.23 
To overcome the first problem, fixative is changed from 95% 
ethanol to 4% formaldehyde in 65% formalin.
23 
Alcoholic formalin differentiates RNA from DNA in subsequent 
staining because of acidic PH (PH-5). It renders the nucleoli red and 
colours more vibrant.
25
 
The last three problems can be overcome by chan and kung’s 
rehydration of air-dried smears. Air drying allows the cells to stick firmly 
21 
 
to the glass slide and the rehydration in normal saline allows RBCs to 
hemolyse, unmasking the cells for morphologic analysis.
23 
The chief limitation of ultrafast papanicolaou stain, is that Richard 
Allan Haematoxylin (RA-H) and Richard Allan cytostain (RA-C), used in 
the staining procedure are not universally available.
25
 
MM Kamal and MM Munshi (2000) made two modifications in the 
ultrafast pap stain. 
First, Instead of Richard Allan Haematoxlyin (RA-H), Gill’s 
Haematoxlyin is used. 
Second, modification was instead of Richard Allan cytostain (RA-
C) which is an Alcoholic mixture of orange G, Eosin Y, Light Green and 
Aniline blue, they used EA modified which is an alcoholic mixture of 
Eosin Y, light green, Phosphotungstic acid and glacial acetic acid.
25
 
As orange G was omitted from the staining solution in Modified 
ultrafast pap stain, orange discoloration was no longer a problem. 
Modified ultrafast papanicolaou stain can be used for tissues where 
chances of cytoplasmic keratinization is negligible. 
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MODIFIED ULTRAFAST PAPANICOLAOU STAIN: 
0.9% Normal saline (30sec) 
Alcoholic formalin (10 sec) 
6 dips in tap water 
Gill’s Haematoxylin (30 sec) 
6 dips in tap water 
95% Alcohol (6 dips) 
EA Modified (15 sec) 
95% Alcohol (6 dips) 
100% Alcohol (6 dips) 
Xylene (6 dips) 
Modified ultrafast papanicolaou (MUFP) is useful in rapid 
assessment of adequacy of smears and for intra operative FNA 
consultations.
25,27
 
“Priyanka and Sudhamani et al. showed that Harri’s 
hematoxylin gives good staining as much as Gill’s hematoxylin in 
MUFP”.33 
23 
 
A study was conducted by Junko Maruta and Hironobu Hashimoto 
et al., in 2002 showed the applicability of modified ultrafast stain for 
quick diagnosis of thyroid diseases. 
Two specimens from each of 251 thyroid aspirations (120 
malignant and 131 benign) were prepared using the modified ultrafast 
stain and the standard papanicolaou stain. The sensitivities of cytologic 
diagnosis in specimens stained by standard papanicolaou method and the 
modified ultrafast method were 95.0% and 93.3% respectively, and the 
specifities were 99.2% and 97.7% respectively.
22
 
Another study done by Grace C.H.Yang and Doreen et all in 2001 
on ultrasound guided FNA of thyroid showed that MUFP  high lighting 
the “orphan Annie-eyed” clear nuclei, helped to differentiate follicular 
variant of papillary thyroid Carcinoma from follicular neoplasms.
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MM Kamal and MM Munsi et al., done a study on ‘Efficacy of 
modified ultrafast papanicolaou stain for Breast aspirates’ in 2000. 
In this study smears from FNA from 100 breasts lumps were 
stained by the MUFP stain. Eighty six breast aspirates are adequate for 
interpretation. Smears showed transparent cells with crisp nuclear 
features, equal to and even better than the conventional papanicolaou 
stain, in a blood free background.
25
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Shinde and Ajita et al., done a study on ‘Application of Modified 
ultrafast papanicolaou stain in cytology of various organs’ in 2005. In 
their study, Group-I included 40 FNAC smears of various organs. In each 
case, three smears were prepared and stained by MUFP, Papanicolaou, 
and MGG stains. 
For assessment of MUFP stain, scores were given on four 
parameters; background of smears, overall staining pattern, cell 
morphology and nuclear staining. Quality index was calculated from ratio 
of score achieved to maximum possible score. Diagnosis made by MUFP 
stain was compared with standard stains. The diagnosis was correct 
except in three cases of metastatic squamous cell carcinoma. Hence, it 
was concluded that MUFP stain is useful for rapid diagnosis by FNAC, 
but is not useful for squamous cell lesions.
29
This is because Orange G is 
not being used in this method. 
        Luciano.B Lemos and Mithra Baliga in 1997 did a one year 
study in Fine Needle Aspiration and concluded that ultrafast 
papanicolaou stain is particularly useful in diagnosing squamous 
carcinoma because of the bright orange staining it imparts to keratinizing 
squamous carcinoma cells, which is an important consideration in the 
diagnosis of many head and neck carcinomas as well as metastatic 
carcinoma.
31
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 Kenji Bando and Reiji Haba et al., done a study on “Utility of 
Immediate cytologic Diagnosis of Lung masses using ultrafast 
papanicolaou stain” in 2011. In this study out of 503 cases investigated, 
the results of immediate cytology using ultrafast pap stain were positive 
in 348 cases and negative in 153 cases. The study concluded that 
immediate cytology can be implemented fairly easily in any hospital, and 
is superior technique for obtaining high diagnostic accuracy.
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Priyanka Choudhary and Sudhamani S et al., did a study on 
‘Comparison of MUFP with the standard rapid papanicolaou stain in 
cytology of various organs’ in 2012.  In this study a total of 100 FNAC 
cases were studied by random sampling. Two smears were prepared for 
each case and stained by both the MUFP and the rapid pap stain. Scores 
were given and the quality index was calculated, followed by the 
statistical analysis. The cases included lymph node (43), thyroid (25), 
breast (23), salivary gland (02), and soft tissues (07)”. 
Scores were given on four parameters: 
Background of smears, Overall staining pattern,  
Cell morphology and nuclear staining. 
Quality index was calculated from the ratio of score achieved to the 
maximum score possible. The study concluded that quality index of 
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MUFP smears was better compared to the rapid pap stain in all the 
organs, and was statically significant.
33 
Another study was conducted by 
Shuji Bandoh and Jiro Fujita et al., in 2013 on ‘Diagnostic Accuracy and 
safety of Flexible Bronchoscopy with Multiplanar
 
Reconstruction images 
(MPR) and Ultrafast Papanicolaou Stain (UFP). 
 
This study includes one hundred consecutive patients with solitary 
pulmonary nodule who underwent bronchoscopy with multiplanar 
reconstruction and MUFP stain. The total diagnostic accuracy of 
bronchoscopy in the MPR and UFP group (91%) was significantly higher 
compared with the historical control group (58%) [P<0.05]. The 
conclusion of the study was that combined use of MPR image and UFP 
during flexible bronchoscopy improved diagnostic accuracy and safety in 
evaluating solitary pulmonary nodules.
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“M.Kamal and Madhura M.Kulkarni et al., in 2011 did a study to 
find out the efficacy of the ultrafast papanicolaou staining technique for 
immediate cytologic diagnosis and to check specimen adequacy during 
radiologically guided FNAC procedure. In this study Group I included 
238 out patient FNACs, groups II included 59 radiologically guided 
FNACs and group III included 50 cases of intraoperative cytology”. 
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Overall diagnosis was possible in 297(85.6%) cases. Only 8 (2.3%) 
cases could not be diagnosed due to staining difficulties. The overall 
concordance rate was 98%. The conclusion of the study was UFP staining 
technique is an accurate and reliable method for rapid cytology reporting. 
It significantly reduces total turnaround time of the test result, thereby it 
is cost-effective both for the patient and the hospital.
35 
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BREAST 
Although most countries in Europe continue to perform fine needle 
aspiration biopsy (FNB) as their first choice in the investigation of breast 
lesions in both screening and symptomatic populations, the use of core 
needle biopsy (CNB) is increasing.
73
 
A preoperative diagnosis of FNA breast offers several advantages: 
1. Saving of time and relieves the patient’s anxiety by immediate 
diagnosis . 
2. A definitive treatment can be planned and discussed with the 
patient in early. 
3.  If cancer is confirmed, additional imaging studies (bone scan, liver 
scan, etc.)  Can be done preoperatively to determine stage . 
4. With the triple test assessment, many benign conditions can be 
confidently diagnosed by FNB or CNB and surgery avoided. 
5. It is cost-effective and allowing one-step definitive surgery 
including lymph node sampling in malignant cases. 
6. The need for frozen section diagnosis is reduced. 
The place of FNB and CNB in the investigative sequence 
While FNB of a palpable breast lump should generally be preceded 
by mammographic and/or ultrasonographic examination, as the 
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radiological findings help to select the most appropriate area to be 
biopsied, FNB may be performed as the first-line investigation, especially 
in symptomatic and screening populations.
 74,75
 
The main purpose of FNB or CNB of breast lumps is to confirm 
cancer preoperatively and to avoid unnecessary surgery in specific benign 
conditions. 
The role of FNB in the assessment of a breast lump includes: 
1. The diagnosis of simple cysts, 
2. The investigation of suspected recurrence or metastasis in cases of 
previously diagnosed cancer, 
3. The confirmation of inoperable, locally advanced cancer, 
4. The preoperative confirmation of clinically suspected cancer,   
5. The investigation of any palpable lump, clinically benign or 
malignant, as a  guide to clinical management, 
6. The ability to obtain tumor cells for special analysis and research, 
(e.g.) hormone receptor studies, DNA analysis, 
immunohistochemistry, cell kinetics and molecular studies. 
Accuracy of diagnosis in FNB and CNB 
However, in our experience the presence of malignant cells on 
FNB in a palpable mass yields invasive carcinoma at excision in 
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approximately 98% and thus the addition of a CNB only adds additional 
information in a few cases.
.78 
Core biopsy is needed for fibrotic or collagenous lesion and 
suspected invasive lobular carcinoma, as these lesions can be 
paucicellular on FNB.
79 
The reported sensitivities, specificities and positive and negative 
predictive values for FNB vary depending upon, insufficiency of the 
samples (as positive, negative or excluded) and atypical samples are 
categorized as (positive or negative). When insufficent samples and 
atypical and benign findings are presumed to be negative, sensitivities 
range from 43.8% to 95%, specificities from 89.8% to 100%, positive 
predicitive values from 76.2% to 100% and negative predicitive values 
from 46.3% to 98.8%. 
If insufficient samples are excluded, sensitivities and specificities 
improve to a range of 58.3% to 100% and 55% to 100%, respectively, 
with a slight change in the negative predictive value to between 46.6% 
and 98.6%. 
The aim should be sensitivity is not less than 95% and this can be 
achieved by increasing experience. Sensitivity is lower for low-grade 
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carcinomas (invasive and in situ), for lobular carcinoma, and for very 
small and very large cancers.
80,81 
The unsatisfactory sample 
If samples are not obtained by experienced pathologist or if Smear 
preparation is not done  by technical staff and given to the laboratory.  
If the lesion is fibrous in nature with low cellularity,  sclerosed FA, 
desmoplastic ca, or hypertrophic fatty tissue  smears can be of low  
cellularity.A smear with low cellularity must be analysed based on 
clinical findings and  the consistency of the lesion felt by biopsy needle 
passes. 
Poorly prepared smears with crush or drying artifacts or with cells 
trapped in clotted blood should be rejected as unsatisfactory. 
 Overall 20% of samples will have scanty cell content. It includes 
microcalcifications. 
However, ‘unsatisfactory’ samples are mainly occur in benign 
lesions, and malignant microcalcifications yield much more satisfactory 
sample. 
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 Standardized reporting of FNB and CNB samples and quality 
assurance 
A national conference conducted by the National Institute of 
Health in the USA collected the views of many pathologists regarding 
details required on requestion forms, methods of sampling, cytologic 
subcategories and details to be furnished in the cytology report. 
Five categories of FNB reports are recommended: 
 Benign, atypical/indeterminate, suspicious/ probably malignant, 
malignant and unsatisfactory. The benign category is again subdivided 
into ‘benign specific’ and ‘benign NOS’. This includes specific diagnosis 
such as cyst, fibroadenoma, fat necrosis, etc.In  benign NOS, means 
simply non-neoplastic breast lesion, for that radiologic and clinical 
follow-up is mandatory.   
 Complications 
 Complications are uncommon. 
 Hematomas are very rare. Vasovagal reactions may occur. 
Pneumothorax is rare one but most important complication,occur in thin 
patients when the  FNA done in medial breast or axilla is sampled. 
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THYROID 
 For the past five or six decades, fine needle aspiration (FNA) 
cytology of the thyroid has been increasingly utilized for the investigation 
of thyroid lesions.
82
 
The prevalence of thyroid nodules is 4–8% in Western 
populations.
83 
The prevalence of malignancy in solitary cold nodules ranges from 
10% to 44.7%. Simplicity, diagnostic accuracy and most of all cost 
effectiveness, have given FNA the status of the first-line diagnostic test in 
the preoperative evaluation of thyroid lesions. 
With increasing experience, FNA has been shown to be able to 
categorise many benign and malignant lesions and thereby guide 
therapeutic protocols. 
It is also useful in the diagnosis and monitoring of autoimmune 
thyroid lesions, especially in clinically equivocal cases and cases where 
biochemical and immunological parameters are normal or marginally 
abnormal. 
The main indications of FNA in thyroid lesions are the following: 
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1. Evaluation of solitary thyroid nodules (with a view to 
distinguish benign from malignant), 
2. Evaluation of diffuse thyroid lesions (with a view to distinguish 
inflammatory/autoimmune lesions from nodular goiter), 
3. Confirmation and categorization of clinically obvious thyroid 
malignancy (especially anaplastic carcinomas that may require 
preoperative palliative treatment, and Lymphoma and metastatic 
malignancy where surgery is usually not indicated), 
4. To obtain material for ancillary tests/prognostic parameters, 
5. Evaluation of lesions detected initially by imaging, measuring 
1–1.5 cm in diameter with features suspicious of malignancy.86 
FNA has been shown to be the safest and most accurate of 
diagnostic tools in thyroid lesions,
87
 with a sensitivity as high as 93.4%, a 
positive predictive value of malignancy of 98.6%, and a specificity of 
74.9%. 
The accuracy of FNA is distinctly higher in centers where not only 
the interpretation but the needling too is carried out by the pathologist. 
Ultrasonography (US), thyroid function tests, antibody profiles and 
FNA, used in conjunction in selected cases, complement one another. 
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US-guided FNA of thyroid is useful, especially in cystic and multinodular 
lesions harboring malignancy. 
Several studies have compared the accuracy and complications of 
core needle biopsy with that of FNA that has increased adequacy rate but 
reduced sensitivity, especially for papillary carcinoma. 
Combination of core needle biopsy with FNA increases diagnostic 
accuracy but the problem of distinguishing benign and malignant 
follicular neoplasms remains. In general, safety and ease of use of FNA 
outweigh the slight increase in accuracy achieved by core needle biopsy. 
Nomenclature used in reporting 
Reporting of thyroid FNA specimens should follow a standard 
format that is clinically relevant in order to direct management. At the 
National Cancer Institute sponsored thyroid state of the science 
conference in Bethesda in October, 2007, consensus was reached 
regarding indications, pre-FNA requirements, FNA techniques, 
diagnostic terminology, etc. 
The Bethesda System reporting terminology includes six 
categories: non-diagnostic, benign, atypia of undetermined origin, 
Follicular neoplasm (FN/) suspicious of FN, suspicious for malignancy 
and malignant.
88 
Every category carries with it the implied risk for 
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malignancy. Each category should be further qualified as to the possible 
pathological entity. 
If an indeterminate diagnosis is being made due to features 
suspicious but not diagnostic of a neoplasm, we suggest the revised 
Papanicolaou system of reporting
89
 which is simple and easily 
reproducible with the following six categories that are useful in triaging 
patients for either clinical follow-up or surgery. 
• Unsatisfactory, 
• Benign, 
• Atypical cellular lesion, 
• Follicular neoplasm, 
• Suspicious for malignancy, 
• Positive for malignancy. 
Accuracy and limitations of cytodiagnosis 
In experienced hands, and in situations where the pathologist 
performs the needling, cytology can be a very sensitive tool with 
sensitivity and specificity of up to 94% and 98% for the diagnosis of 
malignant lesions and nearly 90% accuracy rates for the identification of 
malignancy if follicular lesions are excluded.
90,91
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Cytologic diagnosis is generally accurate in thyroiditis, usual type 
of Papillary Carcinoma PC, medullary carcinoma (MC), anaplastic 
carcinoma (AC) and high-grade lymphoma. 
False negatives generally occur in cystic lesions harboring 
malignancy, in low-grade or intermediate-grade lymphomas occurring in 
a background of Hashimoto’s thyroiditis (HT), in AC with necrosis, in 
focal involvement of the gland by thyroiditis and in cases with dual 
pathology where the dominant non-neoplastic lesion overlies or obscures 
a small carcinoma.
92,93
 
False negatives have been shown to be minimized by using US-
guided FNA. The false positive rate can be reduced further by excluding 
indeterminate follicular lesions. 
Complications  
There are no contraindications to thyroid FNA. 
 Local hemorrhage may be caused by needling, occasionally 
causing a hematoma in the anterior neck.
94
 that in turn may cause airway 
compression
95
 
Carotid hematoma is an extremely rare complication
.96
  
Transient vocal cord paralysis 97 
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Acute transient goiter,
98 
acute suppurative thyroiditis,
99
 
Needling may convert a hot nodule to a cold one and vice versa, 
therefore scans (and in general, all noninvasive investigations) should be 
done before FNA. 
Hemorrhage, necrosis or infarction caused by needling may 
occasionally obscure the histological pattern of thyroid neoplasms. 
Cellular and vascular granulation tissue of organizing hematoma or 
necrosis can mimic sarcoma or angiomatous tumors. Fibrosis, papillary 
hyperplasia, calcification, cholesterol clefts, vascular thrombosis and 
capsular distortion simulating invasion are other worrisome histological 
alterations that occasionally follow needling.
100 
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LYMPH NODE 
“Lymphadenopathy is a commonly encountered clinical problem 
which has a multitude of causes. The commonest cause of peripheral 
lymphadenopathy is a non-specific reactive hyperplasia in which the 
underlying etiology is infrequently found (probably an asymptomatic 
inflammatory process)”. 
In general practice, less than 1% of patients with peripheral 
lymphadenopathy have a malignant process. 
         In comparison, retroperitoneal or intra-abdominal lymphadenopathy 
is usually malignant. 
In contrast, in young patients, intrathoracic lymphadenopathy is 
often associated with infectious mononucleosis, sarcoidosis and 
tuberculosis. 
The likelihood of malignant disease as a cause of peripheral 
lymphadenopathy increases over the age of 40 years, nodes over 2 cm in 
size, firm or matted nodes and non-tender/non-painful node.
59 
Fine needle biopsy (FNB) offers the alternative of an immediate, 
preliminary, although not always specific diagnosis with little trauma and 
cost, thus providing ample information for further management.
60 
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The place of FNA in the investigative sequence 
As a rule, cytological examination of FNB smears can determine 
whether lymphadenopathy is due to reactive hyperplasia, infection, 
metastatic malignancy or malignant lymphoma. 
In order to make the most rational use of fine needle aspiration 
cytology (FNAC), clinicians and pathologists alike must understand and 
accept that the aims and purpose of FNB of peripheral lymph nodes at the 
‘primary’ or ‘community’ level are different from those at the 
‘secondary’ or ‘specialist’ level. 
At the primary level, FNAC is used as a triage to distinguish 
between cases of lymphadenopathy with a high or a low level of 
suspicion of significant disease by the simplest, least invasive and least 
costly method. 
This preliminary assessment is based on routine cytologic smears 
only. 
At the specialist/secondary level, the role of FNB is to provide 
material for further cytomorphologic analysis and for ancillary studies.  
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The aim is to arrive at a definitive diagnosis and lymphoma typing 
making full use of the armamentarium of ancillary laboratory techniques. 
This also applies to most abnormal lymph nodes in deep sites. 
Lymph nodes clinically suspected of metastatic malignancy 
constitute one of the commonest indications for FNB. 
In patients without a previous malignant diagnosis, not only can 
metastatic malignancy be confirmed by FNB, but clues to the nature and 
site of the primary can also be given in most cases. 
In addition, a specific diagnosis by FNB of disseminated 
carcinoma of the prostate, breast, ovary and thyroid, germ cell tumors and 
neuroendocrine carcinoma should be pursued since treatment is available.  
The value of FNB in the investigation of suspected lymphoma can 
be summarized as follows: 
1. At the community/general practitioner level, a preliminary 
cytological diagnosis suggests appropriate management/referral 
and further investigations without delay. 
2. A representative node can be selected for surgical biopsy by FNB 
sampling of multiple nodes. The biggest or the most easily 
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accessible node is not always the most suitable and may show only 
reactive change. 
3.  If a suspicion of lymphoma is known beforehand, any surgical 
tissue specimen will be used to ensure a complete immunologic 
investigation and the preparation of imprint smears to provide 
additional cytonuclear detail. 
4.  Other biopsies – bone marrow, liver, spleen – can be coordinated 
with node excision, saving time and additional anesthesia. 
5.  In patients with advanced intra-abdominal or mediastinal 
lymphoma without involvement of superficial nodes, FNB 
combined with FCM and clinical and radiological assessment of 
the extent of disease may be a sufficient basis for therapeutic 
decisions. Alternatively, a CNB, with or without FNB, can be used 
to obtain more tissue for ancillary studies, a greatly expanded 
immunopanel and to give some idea of tissue and 
immunoarchitecture.
61,62
 Surgical intervention, with its risk of 
morbidity, to obtain tissue for histologic examination can be 
avoided. 
6. Suspected recurrent or residual disease in patients with previously 
confirmed lymphoma can be substantiated by FNB alone.
63
 Any 
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change in the type or grade of lymphoma will also usually be 
recognized. Since the recurrent tumor may be the only sign of 
disease by which the response to systemic therapy can be 
monitored, it is best left intact. 
7. At the secondary/specialist level, an accurate lymphoma subtype 
may be provided when supported by a range of ancillary studies 
and by appropriate expertise. 
Accuracy of diagnosis 
“The accuracy of FNAC of lymph nodes in the diagnosis of 
metastatic malignancy is influenced by many factors such as the size and 
site of the node, fibrosis, necrosis, previous irradiation and the number of 
punctures made. 
Diagnostic sensitivity is occasionally limited by the fact that small 
metastatic deposits, metastases confined to the subcapsular sinus and 
single-cell metastases can be missed. 
However, early micrometastases rarely produce significant lymph 
node enlargement and if a lymph node is palpable it is likely to contain 
enough tumor tissue to be detectable by FNB. The diagnostic sensitivity 
of metastatic and recurring malignancy reported in the literature is usually 
above 95%.
64,65 
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Failure to obtain a representative sample is responsible for most 
false-negative diagnoses. 
Thus, although a negative cytological report makes malignancy 
unlikely, it is not singularly diagnostic, and if the lymphadenopathy does 
not show signs of regression within a month or two, FNB should be 
repeated or a node should be excised for histology. 
Diagnostic specificity for malignancy, on the other hand, is high. 
False-positive diagnoses are rare,
66-67
 if particular caution is observed in 
the interpretation of smears from nodes in fields of previous irradiation 
and in the presence of necrosis. 
Diagnostic accuracy not only depends on the aspirate being 
representative, but also very much on the quality of the cytological 
preparations. 
Diagnostic sensitivity has generally been found to be lower for 
lymphoma than for metastatic malignancy. 
In an extensive review of the literature, two-thirds of the 30 studies 
reviewed, in which FNB was supplemented by immunophenotyping, 
diagnostic sensitivity was over 80% and specificity over 90%. 
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As a rule, FNB samples from malignant lymphoma are very 
cellular and can be used for ancillary studies.
68 
The FNB provides superior cytomorphology and is an excellent 
source for flow cytometry cell suspensions. This combined approach can 
increase diagnostic accuracy, assist in classification and reduce the 
number of insufficient samples.
69,70
 
Complications: 
Significant complications do not occur. Post-aspiration hematoma 
or necrosis is rare. To date, septic complications or tumor implantation in 
the needle track have not been reported following FNB of lymph nodes.  
Technical considerations 
Both reactive nodes and nodes involved by metastatic malignancy 
or lymphoma are highly cellular and moderately vascular tissues. 
Sufficient material is therefore easily obtained using 23–27-gauge 
needles, except sometimes in the presence of fibrosis or necrosis.
71,72 
FNB without aspiration has been used routinely for several years in 
some institutions. It has the advantage over the traditional aspiration of 
giving the operator a more direct and sensitive feeling of the consistency 
of tissues through the needle. This is helpful when small or deep nodes 
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are biopsied. Non-aspiration also results in less admixture with blood. An 
abundance of blood adversely affects cell fixation and tends to cause 
shrinkage and distortion of cells. 
If aspiration is used, multiple rapid biopsies from different points 
of entry are preferable to multiple passes in different directions, in order 
to obtain a representative and adequate sample without too much blood. 
It is not easy to make perfect direct smears from samples of 
lymphoid tissue and this takes considerable practice. An air-dried smear 
has to dry quickly for optimal fixation and has to be made thin and even. 
The smearing pressure must be well balanced to obtain a thin 
smear and at the same time avoiding crush artifacts. If the aspirate is 
bloody or thinned by a large amount of lymph fluid, cells need to be 
concentrated and separated as much as possible from the fluid. A wet-
fixed smear must be fixed immediately to minimize drying artifacts.
59
 
While air-dried MGG or Diff-Quik-stained smears are essential for 
the evaluation of cytoplasm and background elements, alcohol fixation 
and staining with H&E or Pap is helpful in assessing nucleoli and 
chromatin pattern. Whenever possible, both air-dried and wet-fixed 
smears should be made of each FNB sample as they may provide 
complementary information.
.68 
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MATERIALS AND METHODS 
This prospective study was carried out in Department of pathology, 
Coimbatore medical college, Coimbatore. During July 2015 to June 2016. 
Study includes fine needle aspiration from lesions of various organs i.e., 
thyroid, breast, and lymph nodes.  
Total number of cases studied - 100 
Thyroid - 40 
Breast - 40 
Lymph node – 20 
Graph No: 1 Case distribution 
 
 
Thyroid 
40% 
Breast 
40% 
Lymphnode 
20% 
Case Distribution [N=100] 
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PROCEDURE FOR SMEAR PREPARATION AND FIXATION: 
The Fine needle aspiration was done in our hospital by standard 
technique. A minimum 3 smears were obtained on glass slides. Out of 
which 1 smear was fixed in 95% ethanol for a minimum of 15 minutes. 
These smears were stained for pap. 
 The remaining 2 smears were air dried out of which one was 
stained by MGG stain and other smear was rehydrated with normal saline 
and subsequently fixed in alcoholic formalin and stained by MUFP stain. 
Inclusion Criteria 
Fine needle aspirations from thyroid, breast, and lymph node 
lesions done in central laboratory, Department of Pathology, Coimbatore 
medical college, Coimbatore. 
Exclusion Criteria: 
1. Fine needle aspiration from other organs   
2. Cervical cytology  
3. Inadequate material on FNAC 
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STAINING PROCEDURES OF PAP, MGG AND MUFP 
PAPANICOLAOU METHOD 
REAGENTS REQUIRED: 
1.      Harri’s Haematoxylin 
          (Without acetic acid) 
 2.      Orange G 6 (OG 6). 
0.5 Orange G in 95% alcohol 100 ml 
          Phosphotungstic acid                                      0.15g. 
3.      Eosin azure 36 (EA 36 OR EA 50) 
         0.5 Light green SF yellow in 95% alcohol       45ml 
         0.5% Bismark brown in 95% alcohol              10 ml 
         0.5% Eosin Y in 95% alcohol                          45 ml 
         Phosphotungstic acid                                       0.2 g 
        Saturated aqueous lithium carbonate               1 drop 
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TECHNIQUE: 
1. Smears are fixed (while still moist) in 95% alcohol – 15 mints. 
2.  Rinse in distilled water. 
3. Stain with Harri’s haematoxylin for 4 mints. 
4. Wash in tap water for 1-2 mints. 
5. Differentiate with acid alcohol (25% HCL in 70% alcohol). 
6. Blue in tap water or 1.5% sodium bicarbonate. 
7. Rinse the smears in distilled water. 
8. Transfer to 70% alcohol and then 95% alcohol for a few seconds. 
9. Stain with O G6 for 1-2 minutes. 
10. Rinse in 3 changes of 95% alcohol for a few seconds. 
11. Stain in EA 50 for 3 – 5 minutes. 
12. Rinse in 3 changes of 95% alcohol for a few seconds. 
MAY GRUNWALD GIEMSA STAIN (MGG) 
Stock Solution of MGG: 
0.5 grams of MGG powder dissolved in 100 ml of methanol. 
Stock Solution of Giemsa: 
0.75 grams of Giemsa Powder dissolved in 100 ml of methanol. 
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Working Solution of MGG: 
Two parts of Stock Solution of MGG and one part of methanol. 
Working Solution of Giemsa: 
One part of Stock Solution of Giemsa and nine parts of distilled water. 
Staining Technique: 
Stain with Working Solution of MGG in 1-2 minutes. 
Dilution with Working Solution of Giemsa 10 minutes and wash in tap 
water and dry. 
REAGENTS USED IN MUFP STAIN: 
1. Normal Saline 
2. Alcoholic Formalin- 3 liters of alcoholic formalin was prepared by the 
following (pH 5) 
 40% Formalin-300 ml 
 95% Alcohol-2053ml 
 Distilled water-647ml 
3. Gill’s Hematoxylin 
4. 95% Alcohol 
5. 100% Alcohol 
6. Tap water 
7. EA- 50 
8. Xylene 
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MODIFIED ULTRAFAST PAPANICOLAOU STAIN (MUFP) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Air dried smears 
 Hydration with Normal saline 
(30sec) 
Alcoholic Formalin (10 secs) 
Tap water (6 dips) 
1% Gills hematoxylin (30 secs) 
Tap water (6 dips) 
95% Ethanol (6 dips) 
EA-50 ,15 sec (4 dips) 
95% Ethanol (6 dips) 
100% alcohol (6 dips) 
Xylene (10 dips) 
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SCORING SYSTEM USED IN ASSESSMENT OF STAINING: 
PARAMETER SCORE=1 SCORE=2 SCORE=3 
Background Hemorrhage Clean  
Overall staining Poor Average Good 
Cell morphology 
Poorly 
Preserved 
Moderately 
Preserved 
Well 
Preserved 
Nuclear 
Characteristics 
Smudgy 
Chromatin 
Moderately 
Crisp 
Chromatin 
Crisp 
Chromatin 
Cytoplasmic 
details 
Unsatisfactory Suboptimal Optimal 
Air drying 
artifacts 
>50% <50% 0% 
 
The maximum score was 17 for a single case, it was consider into 
account of all the six parameters, 
The “Quality Index” was calculated as the ratio of actual score 
obtained to the maximum score possible. 
Quality Index= actual score obtained /maximum score(17) 
Quality Index for each of the three stains of the three organs was 
compared. 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
OBSERVATION AND RESULTS 
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OBSERVATION AND RESULTS 
Table No: 1 Age distribution of cases studied 
Age Distribution 
     
 
Cases 
 
Age Thyroid Breast Lymph node Total 
<20 5 6 0 11 
21-30 8 6 2 16 
31-40 13 7 4 24 
41-50 9 12 5 26 
51-60 3 6 3 12 
61-70 2 2 4 8 
>70 0 1 2 3 
Total 40 40 20 100 
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Graph No: 2 Age distribution 
 
Case distribution in thyroid is maximum in 31-40(33%) age group 
and 41-50 (23%) years. 
Case distribution in lymph node is maximum in  41-50 (25%) age 
group and 31-40 (20%) and 61-70(20%) years. 
        Case distribution  in breast is maximum in  41-50 (30%) age group  
and 31-40(18%) years. 
 
 
 
 
<20 21-30 31-40 41-50 51-60 61-70 >70 
Thyroid 13% 20% 33% 23% 8% 5% 0% 
Breast 15% 15% 18% 30% 15% 5% 3% 
Lymph node 0% 10% 20% 25% 15% 20% 10% 
0% 
5% 
10% 
15% 
20% 
25% 
30% 
35% 
Age Distribution [N=100][p>0.05] 
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Table No: 2 Association of gender with study cases 
 
  Cases   
Gender Thyroid Breast 
Lymph 
node Total 
Male 1 2 9 12 
Female 39 38 11 88 
Total 40 40 20 100 
 
Graph No.3 Association of gender with study cases 
 
 
Gender distribution of patients is significant. 
Thyroid lesions are more common in females (98%). 
Breast lesions are more common in females (95%). 
Lymph node lesions are also common in females (95%). 
  
0% 
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Thyroid Breast Lymph node 
Female 98% 95% 55% 
Male 3% 5% 45% 
Association of Gender with study cases [N=100][p<0.001] 
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Clinical DiagnosisMean SD Lower Upper Minimum Maximum Sig
PAP Thyroid 0.83 0.06 0.81 0.85 0.71 0.94
Breast 0.87 0.04 0.86 0.88 0.82 0.94 <0.001
Lymph node 0.89 0.03 0.88 0.91 0.82 0.94
MGG Thyroid 0.76 0.06 0.74 0.78 0.59 0.94
Breast 0.77 0.04 0.76 0.78 0.71 0.88 <0.001
Lymph node 0.78 0.04 0.76 0.80 0.71 0.88
MUFP Thyroid 0.94 0.04 0.92 0.95 0.88 1.00
Breast 0.94 0.03 0.93 0.95 0.88 1.00 >0.05
Lymph node 0.96 0.03 0.94 0.97 0.88 1.00
95% CI for Mean
Table No: 3 Mean Quality index of study Groups 
 
Graph No: 4 Mean Quality index of study Groups 
 
 
 
In thyroid maximum Quality Index score was seen in MUFP stain 
followed by pap and MGG stain. 
In breast maximum Quality Index score was seen in MUFP stain 
followed by Pap and MGG stain. 
In lymph Node maximum Quality Index score was seen in MUFP stain 
followed by Pap  and MGG stain.  
Thyroid Breast 
Lymph 
node 
Thyroid Breast 
Lymph 
node 
Thyroid Breast 
Lymph 
node 
PAP MGG MUFP 
Mean 0.83 0.87 0.89 0.76 0.77 0.78 0.94 0.94 0.96 
0.00 
0.20 
0.40 
0.60 
0.80 
1.00 
1.20 
Mean Quality Index of study Groups 
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 Before calculating mean statistics were applied first to specific organ and 
then inter organ comparision was calculated. 
Table No: 4 Associations of Clinical Variables with Study Subjects in 
Thyroid 
  Cases [n=40]   
  PAP   MGG   MUFP   Sig 
Background n % n % n %   
· Hemorrhagic  30 75% 31 78% 0 0%   
· Clean 10 25% 9 23% 40 100% <0.001 
Overall staining             
· Poor  0 0% 1 3% 0 0%   
· Average  21 53% 36 90% 7 18% <0.001 
· Good  19 48% 3 8% 33 83%   
Cell morphology             
· Poorly preserved  0 0% 2 5% 0 0%   
· Moderately 
Preserved 14 35% 35 88% 5 13% <0.001 
· Well preserved  26 65% 3 8% 35 88%   
Nuclear characteristics             
· Smudgy Chromatin  0 0% 8 20% 0 0%   
· Mod crisp 
Chromatin 
4 
10% 29 73% 15 38% <0.001 
· Crisp chromatin  36 90% 3 8% 25 63%   
Cytoplasmic details             
· Unsatisfactory  0 0% 0 0% 0 0%   
· Sub-optimal  20 50% 4 10% 9 23% <0.001 
· Optimal  20 50% 36 90% 31 78%   
Air drying artifacts             
· >50%  0 0% 0 0% 0 0%   
· <50%  27 68% 7 18% 7 18%   
· 0%  13 33% 33 83% 33 83% <0.001 
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FNAC OF 40 THYROID LESIONS YIELDED FOLLOWING 
RESULTS 
Clean background was seen in 40(100%) cases of MUFP cases and in 
10(25%) cases of Pap. Hemorrhagic background was seen in 31(78%) 
cases of MGG. 
83% of MUFP cases showed good overall staining. 48% of Pap and 8% 
of MGG cases showing good overall staining. 90% of MGG cases 
showed average overall staining. 
 Well preserved cell morphology was seen in in 88% of MUFP, 65% of 
Pap and 8% of MGG cases. 
Nuclear characteristics of crisp chromatin was seen in 63% of MUFP 
cases 90% of Pap and 8% of MGG cases. 90% of MGG stain showed 
moderately crisp chromatin. 
90% of MGG stain showed optimal cytoplasmic details, 78% of MUFP 
and 50% of Pap stain showed optimal cytoplasmic details. 50% of Pap 
cases showed sub-optimal cytoplasmic details.  
  Least air drying artifacts were seen in MGG (83%) and air dried 
rehydrated smears like MUFP(83%).  
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Table No: 5 Association of Clinical Variables with Study Subjects in 
Breast 
 
Cases [n=40] 
 
 
PAP 
 
MGG 
 
MUFP 
 
Sig 
Background n % n % n % 
 
· Hemorrhagic 20 50% 32 80% 0 0% 
 
· Clean 20 50% 8 20% 40 100% <0.001 
Overall staining 
       
· Poor 0 0% 2 5% 0 0% 
 
· Average 11 28% 36 90% 6 15% <0.001 
· Good 29 73% 2 5% 34 85% 
 
Cell morphology 
      
· Poorly preserved 0 0% 3 8% 0 0% 
 
· Moderately Preserved 14 35% 31 78% 7 18% <0.001 
· Well preserved 26 65% 6 15% 33 83% 
 
Nuclear characteristics 
      
· Smudgy Chromatin 0 0% 3 8% 0 0% 
 
· Mod crisp Chromatin 5 13% 32 80% 13 33% <0.001 
· Crisp chromatin 35 88% 5 13% 27 68% 
 
Cytoplasmic details 
      
· Unsatisfactory 0 0% 0 0% 0 0% 
 
· Sub-optimal 15 38% 4 10% 7 18% <0.01 
· Optimal 25 63% 36 90% 33 83% 
 
Air drying artifacts 
      
· >50% 0 0% 0 0% 0 0% 
 
· <50% 23 58% 5 13% 7 18% 
 
· 0% 17 43% 35 88% 33 83% <0.001 
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FNAC OF 40 BREAST LESIONS YIELDED FOLLOWING 
RESULTS: 
Clean background was seen in 100% of MUFP and 50% of Pap stain. 
80% of MGG stain showed hemorrhagic background. 
 85%of MUFP and 73% of Pap stain showed good overall staining.  36 
cases (90%) of MGG showed average overall staining. 
 Well preserved cell morphology seen in 83% of MUFP and 65% of pap 
stained smears.  78% of MGG cases showed moderately preserved cell 
morphology. 
Crisp nuclear chromatin was seen in 88% of Pap and 68 % of MUFP 
cases. 80% of MGG stain showed moderately crisp nuclear 
characteristics. 
90% of MGG, 83% of MUFP and (63%) of pap stain showed optimal 
cytoplasmic details . 
  88% of MGG 83% of MUFP and 43% of Pap cases showed no air 
drying artifacts. 
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Table No: 6 Association of Clinical Variables with Study Subjects in 
Lymph Node 
  Cases [n=20]   
  PAP MGG MUFP Sig 
Background n % n % n % 
 
· Hemorrhagic  12 60% 16 80% 0 0% 
 
· Clean 8 40% 4 20% 20 100% <0.001 
Overall staining 
       
· Poor  0 0% 0 0% 0 0% 
 
· Average  7 35% 16 80% 3 15% <0.001 
· Good  13 65% 4 20% 17 85% 
 
Cell morphology 
      
· Poorly preserved  0 0% 0 0% 0 0% 
 
· Moderately Preserved 3 15% 19 95% 2 10% <0.001 
· Well preserved  17 85% 1 5% 18 90% 
 
Nuclear characteristics 
      
· Smudgy Chromatin  0 0% 2 10% 0 0% 
 
· Mod crisp Chromatin 2 10% 17 85% 3 15% <0.001 
· Crisp chromatin  18 90% 1 5% 17 85% 
 
Cytoplasmic details 
      
· Unsatisfactory  0 0% 0 0% 0 0% 
 
· Sub-optimal  6 30% 0 0% 2 10% <0.05 
· Optimal  14 70% 20 100% 18 90% 
 
Air drying artifacts 
      
· >50%  0 0% 0 0% 0 0%   
· <50%  6 30% 2 10% 4 20%   
· 0%  14 70% 18 90% 16 80% >0.05 
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FNAC OF 20 LYMPH NODE LESIONS YIELDED FOLLOWING 
RESULTS: 
100% of MUFP and 40% of pap stain showed clean background.  80% of 
MGG cases showed hemorrhagic background. 
85% of MUFP and 65% of Pap cases showed good overall staining. 80% 
of MGG cases showed average overall staining.  
 95% of MUFP and 85% of Pap cases showed well preserved cell 
morphology. 95% MGG cases showed moderately preserved cell 
morphology. 
Crisp nuclear chromatin was seen in 90% of Pap and 85% of MUFP stain. 
85% of MGG cases showed moderately crisp nuclear characteristics. 
100% of MGG, 90% of MUFP and 70% of Pap cases showed optimal 
cytoplasmic details. 
 90% of MGG,80% of MUFP and70% of Pap stain showed no air drying 
artifacts. 
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RESULTS OF SPECIFIC STAIN IN DIFFERENT ORGANS: 
    
             Table No: 7 Association of PAP QL with study cases 
 
 
Cases 
 
PAP QI Thyroid Breast 
Lymph 
node 
Total 
<0.80 10 0 0 10 
0.81 - 1.00 30 40 20 90 
Total 40 40 20 100 
  
P value of PAP score is <0.001 
Mean Quality index score of Pap stain is maximum for lymph node, 
followed by breast and thyroid.  
Graph No: 5 Association of PAP QL with study cases 
 
 
 
Thyroid Breast Lymph node 
<0.80 25% 0% 0% 
0.81 - 1.00 75% 100% 100% 
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Association of PAP QI with study cases [N=100][p<0.001] 
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Table No: 8 Association of MGG quality Index with Study Cases 
  
  
Cases 
  
MGG QI Thyroid Breast 
Lymph 
node 
Total 
<0.80 33 31 13 77 
0.81 - 1.00 7 9 7 23 
Total 40 40 20 100 
 
Mean Quality index score of MGG stain is maximum for lymph 
node,breast and followed  by thyroid.  
Graph No: 6 Association of MGG QL with study cases 
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Table No: 9 Association of MUFP quality Index with Study Cases 
 
Cases 
 
MUFP QI Thyroid Breast Lymph node Total 
<0.80 0 0 0 0 
0.81 - 1.00 40 40 20 100 
Total 40 40 20 100 
  
Mean Quality index score of MUFP stain is maximum for lymph node 
followed by thyroid and breast. 
                   
Graph No: 7 Association of MUFP QI with study cases 
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Association of MUFP QI with study cases [N=100][p>0.05] 
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Table No: 10 Association of Background with Study cases 
 
 
Cases 
Background PAP MGG MUFP 
· Hemorrhagic 62 79 0 
· Clean 38 21 100 
Total 100 100 100 
 
 
Graph No: 8 Association of Background with study cases 
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Table No: 11 Association of overall staining with Study cases 
 
 
Cases 
Overall staining PAP MGG MUFP 
· Poor 0 3 0 
· Average 39 88 16 
· Good 61 9 84 
Total 100 100 100 
 
 
Graph No: 9 Association of overall staining with study cases 
 
 
 
 
 
PAP MGG MUFP 
· Poor  0% 3% 0% 
· Average  39% 88% 16% 
· Good  61% 9% 84% 
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Table No: 12 Association of cell morphology with study cases 
 
 
Cases 
Cell morphology PAP MGG MUFP 
· Poorly preserved 0 5 0 
· Moderately Preserved 31 85 14 
· Well preserved 69 10 86 
Total 100 100 100 
 
Graph No: 10 Association of Cell Morphology with study cases 
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· Poorly preserved  0% 5% 0% 
· Moderately Preserved 31% 85% 14% 
· Well preserved  69% 10% 86% 
0% 
10% 
20% 
30% 
40% 
50% 
60% 
70% 
80% 
90% 
100% 
Assoication of Cell Morphology with study cases 
[N=100][p<0.05] 
70 
 
Table No: 13 Association of Nuclear Characteristics with Study cases 
 
 
Graph No: 11 Association of Nuclear Characteristics with Study 
cases 
 
 
 
 
 
 
 
 
 
 
 
PAP MGG MUFP 
· Smudgy Chromatin  0% 13% 0% 
· Mod crisp Chromatin 11% 78% 31% 
· Crisp chromatin  89% 9% 69% 
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Cases 
Nuclear characteristics PAP MGG MUFP 
· Smudgy Chromatin 0 13 0 
· Mod crisp Chromatin 11 78 31 
· Crisp chromatin 89 9 69 
Total 100 100 100 
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Table No: 14 Association of Cytoplasmic details with Study cases 
 
 
Cases 
Cytoplasmic details PAP MGG MUFP 
· Unsatisfactory 0 0 0 
· Sub-optimal 41 8 18 
· Optimal 59 92 82 
Total 100 100 100 
 
 
Graph No: 12 Association of Cytoplasmic details with Study cases 
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Table No: 15 Association of Air drying artifacts with Study cases 
 
 
Cases 
Air drying artifacts PAP MGG MUFP 
· >50% 0 0 0 
· <50% 56 14 18 
· 0% 44 86 82 
Total 100 100 100 
 
 
Graph No: 13 Association of Air drying artifacts with Study cases 
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STATISTICAL ANALYSIS 
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STATISTICAL ANALYSIS: 
The data are reported as the mean +/- SD or the median, depending on 
their distribution.          
Frequencies are expressed in percentages.      
ANOVA was used to assess the quantitative variables.   
The chi square test & Fisher Exact test were used  assess differences in 
categ oric variables between groups.       
A p value of <0.05 using a two-tailed test was taken as being of 
significance for all statistical tests. All data were analysed with a 
statistical software package. (SPSS, version 16.0 for windows)  
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FIGURE: 1 
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BREAST 
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FIBROADENOMA BREAST –MUFP 
STAIN (40X) 
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DUCTAL CARCINOMA-MGG STAIN (40x) 
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LYMPH NODE 
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STAIN (40X)  
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STAIN (40X)  
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STAIN (40X) 
 
SQUAMOUS CELL CARCINOMA SECONDARIES IN 
LYMPH NODE, MUFP STAIN, 40X  
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FIGUARE: 18 
  
SQUAMOUS CELL CARCINOMA SECONDARIES IN 
LYMPH NODE, MUFP STAIN, 40X  
 
SQUAMOUS CELL CARCINOMA SECONDARIES IN 
LYMPH NODE, MGG STAIN, 40X 
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DISCUSSION 
Fine needle aspiration cytology (FNAC) is one of the least 
expensive (most economical), quickest and simplest methods available 
for early diagnosis of various palpable and deep seated lesions. Since its 
establisment, PAP stain remains the traditional and most widely used 
stain, not only for the gynecological cytology, but also for various lesions 
of other organ. 
The different staining methods of air dried smears are MGG,  
Jenner-Giemsa and Diff-Quick stain, but they will not offer the 
transparency in the study of subtle nuclear features as seen by the PAP 
stain. 
The conventional pap staining methods proceeds with wet fixation 
and further staining, together required minimum30 minutes. To cut short 
the time,  kline, Tao and sato developed rapid pap stain which required 
staining time of 5minutes, 4minutes and followed by  90 seconds. but, the 
quality of rapid pap stain is usually not good, as the cell morphology is 
not well satisfactory  as seen. 
To overcome these problems, ultra-Fast pap (UFP) stain was 
developed by Yang and Alvarez. It is a hybrid of pap and Romanowsky 
stains. The staining time is 90 seconds. Further modification of UFP 
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stain(Modified ultra-Fast pap stain)  done by Kamal et al from India, to 
overcome the shortage of Richard-Allan hematoxylin and Richard-Allan 
cytostain in Indian set-up. Staining time of this method is 130 seconds 
and with well appreciated cytomorphology . 
In this study, cytomorphology of modified ultrafast papanicolao 
stain(MUFP)  was compared with  conventional papanicolaou stain and 
May Grunwald Giemsa stain. 
MUFP stain-rehydrated air dried smear. 
PAP stain-ethyl alcohol fixed wet smear. 
MGG stain-air dried smear. 
All 3 stains quality was evaluated in six parameters, as 
background, Overall staining, cell morphology, nuclear characteristics, 
cytoplasmic features and air-drying artifacts. 
The quality index of all three stains were calculated and compared 
with various organs like thyroid, Breast and lymph node. 
 Ultrafast pap stain was done in thyroid,breast and lymph node 
lesion by Shinde et al. Quality indices of our study were compared with 
quality indices of Shinde’s study. 
In our study, number of cases higher than the Shinde’s study.  
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Table 16. Quality index of various organs in Shinde’s study and 
                       present study 
For Modified ultrafast pap stain: 
 
Organ 
Shinde’s study Present study 
No. of 
cases 
Quality 
 index 
No. of 
cases 
Quality 
index 
Thyroid 8 0.98 40 0.94 
Breast 16 0.92 40 0.94 
Lymph node 15 0.98 
20 
 
0.98 
 
 Quality index of MUFP stain in the same three organs are compared with 
rapid pap stain by Priyanka Choudhary et al.  
Table 17. Quality index of various organs in Priyanka’s study 
 
Organ No. of cases 
Quality index of 
Mufp 
Thyroid 25 1 
Breast 23 o.97 
Lymphnode 43 0.98 
 
BACKGROUND: 
 More blood staining background is one of the common problem in 
conventionally fixed and staining methods, this is overcome by 
Rehydration of dried smear.  
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 As per table No: 11,   
MUFP show 100% clean background,in which air dried smears are 
rehydrated with normal saline as compared to wet fixed Papanicolaou  
smears(38%) and air dried MGG smears(21%).  
 The P value is <0.05. Calculated by applying chi-square test 
proved  the difference to be significant.  
These values are compared to various studies.  In Shinde’s study 
95% of the MUFP stained smears showed clean background .Choudhary 
P. et al. reported MUFP stain has clean, RBC free background, it is very 
helpful in interpretation of vascular organs like thyroid. Maruta et al. 
Found that MUFP stain lyses blood cells, making the smear much thinner 
and clearer. RBC free background provides better cytomorphologic 
features. 
Rehydration solution of MUFP is normal saline, it was introduced 
by Chang and Kung. It lyses the red blood cells and unmasks the tumour 
cells. This provide transparent air dried cells and well preserved nuclear 
details. Cells were appear larger due to air drying with red stained distinct 
nucleoli.  
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Our study proves that air-dried smears rehydrated with normal 
saline provides clean background as compared to wet fixed and air dried  
smears. 
OVERALL STAINING: 
According to the table no 12:   
 84% of MUFP stain showed good overall staining   followed 
by Pap (61%), and MGG (9%).  88% of MGG stain showed average 
overall staining. 
  P value is <0.05, thus making significant difference Priyanka 
Choudhary et al study also showed over all staining score is maximum for 
MUFP.  
CELL MORPHOLOGY: 
In the table 13:  
Well preserved cell morphology is maximum for MUFP (86%) 
followed by Pap (69%) and MGG stain (10%). 
 Value of P is <0.05.showing statistically significant difference. 
This study is compared to Priyanka Choudhary et al study .this study 
showed MUFP stain got maximum cell morphology score. 
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NUCLEAR CHARACTERISTICS: 
Crisp nuclear chromatin were assesed. 
In the table no14: 
P value is <0.05 showing statistically Significant difference.   
 89% of Pap stain showing crisp nuclear chromatin followed by 
MUFP stain (69%) and MGG stain (9%). 78% of MGG showing 
moderately crisp nuclear chromatin.  
 Follicular variant of papillary carcinoma is easily distinguished 
from follicular neoplasms of the thyroid by UFP stain as it highlights the 
Orphan-Annie-eyed nuclei. This is reported by Yang et al. 
CYTOPLASMIC DETAILS: 
 Grading of cytoplasmic features are unsatisfactory, suboptimal and 
optimal. 
In the table no 15: 
 Optimal cytoplasmic features are seen in 92% of MGG stained 
smears followed by MUFP (82%) and Pap (59%) stain.  
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 P value is <0.05 thus showing statistically significant difference. 
Modified ultrafast staining solution has no Orange G. So it is used in 
tissue with negligible cytoplasmic keratinization. 
AIR-DRYING ARTIFACTS: 
In the table no 16: 
No air drying artifacts are seen in 86% of MGG, 82% of MUFP 
and followed by 44% of Pap stain.  
 P value is <0.05 thus showing statistically significant difference. 
 Kamal et al. found the problem of wet fixation, but the air drying 
artifacts can be eliminated by rehydration of air dried smears as in 
MUFP.  
 Thus our study proved that air drying technique and rehydration of 
air dried smears was associated with less air drying artifacts as compared 
to wet fixation. 
The amount of air drying artifacts also depends upon skill of 
person who makes the smear. Thus with rehydration technique even 
people who are not fully skilled can casually do the procedure without 
much struggle. 
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Our study compares the Modified Ultrafast Papanicolaou Stain 
(MUFP) with conventional Papanicolaou stain and MGG stain. MUFP is 
quick and has the advantage that 
The background is clean and shows very less air drying artifact.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
SUMMARY  
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SUMMARY 
This prospective study was carried over a period of 12 months, 
which included 100 cases (Fine Needle Aspiration Cytology from  
various organs like Thyroid, Breast and Lymph node ). 
Three different Stains, Papanicolaou stain and May- Grunwald 
Giemsa(MGG) and Modified  Ultrafast Papanicolaou stain(MUFP)  were 
compared with each other. 
Smears were compared with six parameters and significance of 
Difference was calculated by applying Chi-square/ Fisher Exact test to 
find the Significance of study parameters on categorical scale between 
two or more groups.  
Statistical Results of specific organ with inter-stain study 
 Thyroid cases - MUFP > PAP > MGG 
 
 Breast cases - MUFP > PAP > MGG  
 
 Lymph Node - MUFP > PAP > MGG 
 
> Means better than 
 
  PAP, MGG, MUFP stains done for thyroid, breast and lymph node 
Lesions. Out of which maximum quality index score was obtained by 
MUFP followed by PAP stain and MGG stain. 
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 Statistical Results of specific stain with inter-organ study 
MUFP stain -   Lymph Node > Breast/thyroid 
PAP stain -Lymph Node > Breast > Thyroid  
MGG stain - Lymph Node > Breast > Thyroid 
 > means better than 
 MUFP smears stain was best for lymph node, breast and thyroid lesion. 
Pap stain showed best for  lesion from lymph node ,followed by breast 
and  thyroid . 
MGG stain was good for lesion from lymph node followed by breast and 
thyroid. 
 
  
  
 
 
 
 
 
 
 
 
 
 
CONCLUSION 
 
84 
 
CONCLUSION 
 Modified ultrafast pap stain is a excellent staining method for 
studying FNA material from all three organs like thyroid, breast and 
lymph node lesions.  
MUFP stain showed maximum score for all four parameters and 
shows optimal cytoplasmic features in 82% of cases and crisp nuclear 
chromatin in 69% cases.   
 Fixative of MUFP stain is alcoholic formalin .It provide lesser 
staining time for fixation and makes nucleoli to appear red and 
prominent, Compared to conventional Pap stain. 
Pap stain is excellent for staining crisp nuclear chromatin and stain 
bipolar nuclei better than MUFP in fibroadenoma.  
MGG stained smears showed less air drying artifacts when 
compared to wet fixed smears and has better optimal cytoplasmic 
features. 
Lesser time for staining along with excellent morphologic 
quality is the need of the hour in any cytology laboratory.  
MUFP very easily fulfils these parameters either equal to or 
even better than pap Technique for cytologic staining and organ 
study. 
MUFP staining is quick, reliable and can be done with easily 
available reagents and is very useful especially in countries like India.    
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ANNEXURES 
  
PROFORMA 
 
Name:                                                                           IP/OP No: 
Age :                                                                             FNAC No: 
Sex: 
Presenting complaints:  
Past history: 
Family history: 
Personal history: 
General Examination : 
Pallor, Lymphadenopathy 
Icterus, Cyanosis 
Clubbing, Oedema 
Pulse rate: 
Blood pressure: 
Respiratory rate: 
Systemic examination:RS , CVS , Per abdomen. 
Investigations: 
Complete blood count 
TFT,Ultrasound 
Local examination: 
Clinical Diagnosis: 
Nature of Aspirate: 
LIST OF ABBREVIATIONS 
FNAC -  Fine Needle Aspiration Cytology 
FNB   -  Fine needle biopsy 
CNB   -  Core needle biopsy  
PAP   -  Papanicolaou 
MUFP  -  Modified Ultrafast Papanicolaou 
MGG  -  May Grunwald Giemsa 
H&E  - Hematoxylin and Eosin 
OG   -  Orange G 
EA   -  Eosin Azure 
QI   -  Quality Index 
FN  - Follicular Neoplasm 
PC  - Papillary Carcinoma 
 
xg;g[jy; gotk; 
 
bgah;   : 
taJ   : 
ghypdk;  : 
Kfthp  :  
 
 vdJ khh]gf fl]oapy] / Kd] fGj]J fHiy fl]oapy] /  bewpfl]oapy] 
,Ue]J Crp \yk] jpR / ePh] vLj]J ghpnrhjid bra]tjw]F KG kdJld] 
rk]kjpf]fpnwd]. 
 
 
 
 
 
,lk; :                                                                                    ,g]gof]F 
njjp :                            ifbahg;gk; / nuif 
 
 
                                      
  
KEY TO MASTER CHART 
 
1. Background   
Hemorrhagic-Score 1                                                                  
 Clean -Score 2              
2. OverallStaining 
Poor -Score1 
Average -Score 2 
Good -Score 3 
3. Cell Morphology                                                                 
Poorly Preserved -Score 1                                                    
Moderately Preserved                                                        
Well Preserved -Score 3                                                           
4. Nuclear Characteristics                                                     
Smudgy Chromatin -Score 1                                                     
Moderately Crisp Chromatin-Score 2    
 Crisp Chromatin -Score 3    
 
     5.  Cytoplasmic Details 
Unsatisfactory-Score1 
Suboptimal -Score 2 
Optimal -Score 3 
6.  Air Drying Artifacts 
>50%-Score 1 
<50%-Score 2 
 0% -score 3
PAPANICOLAOU STAIN 
Sl.No 
Cytology 
no 
Age Sex organ Impression Backround Overall staining 
Cell 
morphology 
Nuclear 
charecteristics 
Cytoplasmic 
details 
Air 
drying 
artifact 
Quality 
index 
1 893/15 45 female thyroid follicular neoplasm 1 3 3 3 3 3 0.94 
2 899/15 33 female thyroid nodular goitre 1 2 3 3 3 3 0.88 
3 906/15 45 female thyroid nodular goitre 1 2 3 3 3 3 0.88 
4 916/15 27 female thyroid nodular goitre 2 3 2 3 2 2 0.82 
5 923/15 48 female thyroid nodular goitre 1 3 2 3 2 2 0.76 
6 925/15 31 female thyroid nodular goitre 1 2 2 3 2 2 0.71 
7 927/15 42 female thyroid nodular goitre 1 2 3 3 2 2 0.76 
8 
947/15 20 female thyroid 
hashimotos 
thyroiditis 1 2 3 3 2 2 0.76 
9 
961/15 20 female thyroid 
hashimotos 
thyroiditis 1 3 2 2 2 2 0.71 
10 1219/15 27 female thyroid nodular goitre 1 2 3 3 2 2 0.76 
11 
1242/15 39 female thyroid 
hashimotos 
thyroiditis 2 2 2 3 3 2 0.82 
12 
1244/15 50 female thyroid 
hashimotos 
thyroiditis 2 2 3 3 2 3 0.88 
13 1285/15 24 female thyroid nodular goitre 2 2 3 3 3 2 0.88 
14 
1303/15 20 female thyroid 
hashimotos 
thyroiditis 1 2 3 3 3 2 0.82 
15 1312/15 32 female thyroid nodular goitre 1 3 3 3 2 2 0.82 
16 
490/16 40 female thyroid 
hashimotos 
thyroiditis 1 3 2 3 3 2 0.82 
17 516/16 46 female thyroid nodular goitre 1 3 2 3 3 3 0.88 
18 518/16 46 female thyroid nodular goitre 1 2 3 3 2 2 0.76 
19 
540/16 32 female thyroid 
hashimotos 
thyroiditis 2 2 3 2 3 2 0.82 
MASTER CHART 
20 541/16 50 female thyroid nodular goitre 2 3 3 3 3 2 0.94 
21 624/16 36 female thyroid nodular goitre 1 3 3 3 2 2 0.82 
22 632/16 34 female thyroid medullary carcinoma 1 3 2 3 2 3 0.82 
23 639/16 62 female thyroid papillary carcinoma 2 2 2 3 2 3 0.88 
24 648/16 29 female thyroid nodular goitre 1 3 3 2 2 3 0.82 
25 732/16 68 female thyroid papillary carcinoma 1 3 2 3 2 3 0.82 
26 782/16 40 female thyroid nodular goitre 2 2 3 3 2 3 0.88 
27 
790/16 39 female thyroid 
hashimotos 
thyroiditis 1 3 3 3 3 2 0.88 
28 
792/16 14 female thyroid 
hashimotos 
thyroiditis 2 2 3 3 3 2 0.88 
29 795/16 20 female thyroid follicular neoplasm 1 3 3 3 3 2 0.88 
30 
800/16 38 female thyroid 
hashimotos 
thyroiditis 1 2 2 3 3 2 0.76 
31 802/16 53 female thyroid nodular goitre 1 2 3 3 3 2 0.82 
32 805/16 28 female thyroid follicular neoplasm 2 2 3 2 3 3 0.88 
33 809/16 51 female thyroid nodular goitre 1 3 3 3 2 3 0.88 
34 
827/16 21 female thyroid 
hashimotos 
thyroiditis 1 3 2 3 2 2 0.76 
35 834/16 28 female thyroid nodular goitre 1 2 3 3 2 2 0.76 
36 840/16 37 female thyroid nodular goitre 1 3 3 3 2 2 0.82 
37 
845/16 53 male thyroid 
hashimotos 
thyroiditis 1 2 2 3 3 3 0.82 
38 852/16 29 female thyroid nodular goitre 1 2 3 3 3 2 0.82 
39 863/16 40 female thyroid nodular goitre 1 3 2 3 3 2 0.82 
40 873/16 41 female thyroid nodular goitre 1 3 3 3 3 2 0.88 
41 890/15 50 female breast ductal carcinoma 2 3 2 2 3 2 0.82 
42 902/15 37 female breast fibrocystic disease 1 3 2 3 3 2 0.82 
43 903/15 18 female breast fibroadenoma 2 3 2 3 2 3 0.88 
44 904/15 63 male breast gynacomastia 2 2 2 3 3 2 0.82 
45 905/15 26 female breast fibroadenoma 2 2 2 3 3 3 0.88 
46 907/15 33 female breast fibroadenoma 2 2 3 3 2 3 0.88 
47 912/15 39 female breast fibroadenoma 1 3 3 3 2 3 0.88 
48 913/15 32 female breast fibrocystic disease 1 3 3 3 2 2 0.82 
49 914/15 24 female breast fibroadenoma 1 3 2 3 3 3 0.88 
50 919/15 20 female breast fibroadenoma 2 3 3 3 3 2 0.94 
51 922/15 38 female breast fibrocystic disease 2 2 3 3 3 2 0.88 
52 926/15 41 male breast gynacomastia 1 3 3 3 3 3 0.94 
53 1265/15 33 female breast fibroadenoma 1 3 3 3 3 2 0.88 
54 1267/15 44 female breast fibroadenoma 2 3 3 3 3 2 0.94 
55 1271/15 46 female breast fibrocystic disease 1 3 2 3 3 2 0.82 
56 1278/15 20 female breast fibroadenoma 1 3 3 3 2 3 0.88 
57 1357/15 62 female breast ductal carcinoma 1 2 3 3 2 3 0.88 
58 495/16 47 female breast ductal carcinoma 2 3 3 3 2 3 0.94 
59 520/16 42 female breast ductal carcinoma 2 2 2 3 2 3 0.82 
60 521/16 55 female breast ductal carcinoma 2 2 3 2 3 3 0.88 
61 612/16 75 female breast ductal carcinoma 2 3 3 2 2 2 0.82 
62 620/16 45 female breast fibrocystic disease 1 3 3 3 3 2 0.88 
63 628/16 58 female breast ductal carcinoma 1 3 2 3 3 2 0.82 
64 658/16 40 female breast ductal carcinoma 1 3 3 3 3 2 0.88 
65 784/16 60 female breast ductal carcinoma 1 2 3 3 3 2 0.82 
66 793/16 45 female breast fibrocystic disease 1 3 3 3 2 3 0.88 
67 804/16 17 female breast fibroadenoma 1 3 3 3 3 2 0.88 
68 810/16 29 female breast fibrocystic disease 2 2 3 3 3 2 0.88 
69 811/16 45 female breast ductal carcinoma 2 3 2 3 2 3 0.88 
70 813/16 57 female breast ductal carcinoma 1 3 3 3 2 3 0.88 
71 814/16 19 female breast fibroadenoma 2 2 3 3 3 3 0.94 
72 833/16 20 female breast fibroadenoma 2 3 3 3 2 2 0.88 
73 839/16 58 female breast ductal carcinoma 2 3 2 2 3 2 0.82 
74 844/16 23 female breast fibrocystic disease 2 3 2 2 3 2 0.82 
75 856/16 47 female breast fibrocystic disease 2 3 3 3 3 2 0.94 
76 864/16 55 female breast ductal carcinoma 2 2 2 3 3 2 0.82 
77 880/16 41 female breast fibrocystic disease 1 3 3 3 2 3 0.88 
78 884/16 26 female breast fibroadenoma 1 3 3 3 3 2 0.88 
79 885/16 30 female breast fibrocystic disease 1 3 3 3 2 3 0.88 
80 886/16 50 female breast ductal carcinoma 1 3 2 3 3 2 0.82 
81 875/15 50 male lymphnode metastatic deposits 1 3 3 3 2 3 0.88 
82 
876/15 38 female lymphnode 
reactive 
lymphadenitis 1 2 3 3 3 3 0.88 
83 883/15 41 female lymphnode suppurative lesion 1 3 3 2 3 3 0.88 
84 890/15 50 female lymphnode metastatic deposits 2 2 3 3 3 2 0.88 
85 891/15 34 female lymphnode suppurative lesion 2 3 2 3 3 2 0.88 
86 894/15 72 male lymphnode metastatic deposits 1 3 3 3 2 3 0.88 
87 1319/15 29 female lymphnode suppurative lesion 1 3 3 3 2 3 0.88 
88 1336/15 67 male lymphnode metastatic deposits 1 2 3 3 3 3 0.88 
89 503/16 60 male lymphnode metastatic deposits 2 2 3 2 3 3 0.88 
90 534/16 22 male lymphnode TB lymphadenitis 2 2 3 3 3 3 0.94 
91 551/16 64 female lymphnode metastatic deposits 2 3 2 3 3 3 0.94 
92 553/16 75 male lymphnode metastatic deposits 1 3 3 3 3 2 0.88 
93 653/16 68 female lymphnode metastatic deposits 1 3 3 3 3 2 0.88 
94 659/16 47 male lymphnode metastatic deposits 1 2 3 3 3 2 0.82 
95 
777/16 32 male lymphnode 
reactive 
lymphadenitis 1 3 3 3 2 3 0.88 
96 789/16 56 female lymphnode metastatic deposits 2 3 3 3 2 2 0.88 
97 
799/16 38 female lymphnode 
reactive 
lymphadenitis 2 3 2 3 3 3 0.94 
98 811/16 45 female lymphnode metastatic deposits 1 3 3 3 2 3 0.88 
99 813/16 57 female lymphnode metastatic deposits 1 3 3 3 3 3 0.94 
100 816/16 66 male lymphnode metastatic deposits 2 2 3 3 3 3 0.94 
 
                                                            
                                                                         
MAY GRUNWALD GEIMSA STAIN 
S.No Backround 
Overall 
staining 
Cell 
morphology 
Nuclear 
charecteristics 
Cytoplasmic 
details 
Air 
drying 
artifact 
Quality 
index 
1 2 2 2 1 3 3 0.76 
2 1 2 2 2 3 3 0.76 
3 1 2 2 1 3 3 0.71 
4 1 2 2 2 3 3 0.76 
5 1 2 2 2 3 3 0.76 
6 1 2 3 2 3 2 0.76 
7 2 2 2 2 3 3 0.82 
8 1 2 2 3 2 3 0.76 
9 1 2 2 2 3 3 0.76 
10 1 2 2 2 3 3 0.76 
11 1 2 2 2 3 3 0.76 
12 2 2 1 2 3 2 0.71 
13 2 3 2 1 3 3 0.82 
14 1 2 2 2 3 3 0.76 
15 1 2 2 2 3 3 0.76 
16 1 2 2 2 3 3 0.76 
17 1 1 2 1 3 2 0.59 
18 1 2 2 1 3 3 0.71 
19 1 2 2 2 3 3 0.76 
20 1 3 3 2 3 3 0.88 
21 1 2 2 2 2 3 0.71 
22 1 2 2 2 3 3 0.76 
23 2 2 2 2 3 3 0.82 
24 1 2 2 1 3 2 0.65 
25 1 2 2 2 3 3 0.76 
26 2 2 3 3 3 3 0.94 
27 2 2 2 2 2 2 0.71 
28 2 2 2 2 3 3 0.82 
29 1 2 2 2 3 3 0.76 
30 1 2 2 2 3 2 0.71 
31 1 2 2 2 3 3 0.76 
32 1 2 2 2 3 3 0.76 
33 1 2 2 2 3 3 0.76 
34 1 2 2 1 3 3 0.71 
35 2 2 1 2 2 3 0.71 
36 1 2 2 3 3 3 0.82 
37 1 3 2 1 3 3 0.76 
38 1 2 2 2 3 3 0.76 
39 1 2 2 2 3 3 0.76 
40 1 2 2 2 3 2 0.71 
41 1 2 2 2 3 3 0.76 
42 1 2 2 2 3 2 0.71 
43 2 2 2 1 3 3 0.76 
44 1 2 2 3 2 3 0.76 
45 1 2 1 2 3 3 0.71 
46 1 2 2 2 3 3 0.76 
47 1 2 2 2 3 3 0.76 
48 1 3 1 2 3 3 0.76 
49 2 2 2 2 3 2 0.76 
50 2 1 3 2 3 3 0.82 
51 1 2 2 2 3 3 0.76 
52 2 2 2 2 3 3 0.82 
53 1 2 2 1 3 3 0.71 
54 1 2 2 3 2 3 0.76 
55 1 2 2 2 3 3 0.76 
56 1 2 2 2 3 3 0.76 
54 1 2 3 2 3 3 0.82 
58 2 2 2 2 3 2 0.76 
59 1 2 2 3 3 3 0.82 
60 1 2 2 2 3 3 0.76 
61 1 2 2 2 2 3 0.71 
62 1 2 2 2 3 3 0.76 
63 2 2 2 2 3 3 0.82 
64 1 2 3 2 3 3 0.82 
65 1 1 3 3 3 2 0.76 
66 1 2 2 2 3 3 0.76 
67 1 2 2 2 3 3 0.76 
68 1 2 2 2 3 3 0.76 
69 1 2 2 2 3 3 0.76 
70 1 2 2 2 3 3 0.76 
71 1 3 3 2 3 3 0.88 
72 2 2 2 1 3 3 0.76 
73 2 2 2 2 3 3 0.82 
74 1 2 2 2 3 3 0.76 
75 1 2 2 2 3 3 0.76 
76 1 2 2 2 3 2 0.71 
77 1 2 2 3 2 3 0.76 
78 1 2 3 2 3 3 0.82 
79 1 2 1 2 3 3 0.71 
80 1 2 2 2 3 3 0.76 
81 1 2 2 2 3 3 0.76 
82 2 2 2 2 3 3 0.82 
83 1 3 2 2 3 3 0.82 
84 1 2 2 1 3 3 0.71 
85 1 3 2 2 3 3 0.82 
86 1 2 2 2 3 3 0.76 
87 1 2 2 2 3 3 0.76 
88 1 2 2 2 3 3 0.76 
89 1 2 2 2 3 2 0.71 
90 1 3 2 2 3 3 0.82 
91 2 2 2 2 3 3 0.82 
92 1 2 2 2 3 3 0.76 
93 1 2 3 3 3 3 0.88 
94 1 2 2 2 3 3 0.76 
95 1 2 2 2 3 3 0.76 
96 1 2 2 2 3 3 0.76 
97 1 3 2 1 3 3 0.76 
98 2 2 2 2 3 2 0.76 
99 1 2 2 2 3 3 0.76 
100 2 2 2 2 3 3 0.82 
 
MODIFIED ULTRA FAST PAP STAIN 
S.No Backround 
Overall 
staining 
Cell 
morphology 
Nuclear 
charecteristics 
Cytoplasmic 
details 
Air drying 
artifact 
Quality 
index 
1 2 3 3 3 3 3 1 
2 2 3 3 3 3 3 1 
3 2 3 3 3 3 3 1 
4 2 3 2 3 3 3 0.94 
5 2 3 3 2 3 3 0.94 
6 2 2 3 2 3 3 0.88 
7 2 3 3 3 2 3 0.94 
8 2 3 3 2 3 2 0.88 
9 2 3 3 2 3 2 0.88 
10 2 3 3 2 3 3 0.94 
11 2 3 3 3 3 3 1 
12 2 3 2 3 3 3 0.94 
13 2 3 3 2 2 3 0.88 
14 2 3 3 3 2 2 0.88 
15 2 2 3 3 2 3 0.88 
16 2 3 3 2 3 3 0.94 
17 2 3 3 3 3 3 1 
18 2 3 3 2 3 3 0.94 
19 2 3 3 3 3 3 1 
20 2 2 3 2 3 3 0.88 
21 2 3 2 3 3 3 0.94 
22 2 3 3 3 2 3 0.94 
23 2 2 3 3 3 2 0.88 
24 2 3 3 3 3 2 0.94 
25 2 3 3 3 2 3 0.94 
26 2 3 3 3 2 3 0.94 
27 2 3 2 3 3 3 0.94 
28 2 3 3 2 3 3 0.94 
29 2 2 3 3 3 2 0.88 
30 2 3 3 3 3 3 1 
31 2 3 3 2 3 3 0.94 
32 2 3 3 3 3 3 1 
33 2 3 3 2 3 3 0.94 
34 2 3 3 2 3 3 0.94 
35 2 2 3 3 2 3 0.88 
36 2 3 3 3 2 3 0.94 
37 2 3 2 3 3 3 0.94 
38 2 3 3 2 3 3 0.94 
39 2 3 3 3 3 2 0.94 
40 2 2 3 2 3 3 0.88 
41 2 3 2 3 3 3 0.94 
42 2 3 3 2 3 3 0.94 
43 2 3 2 3 3 3 0.94 
44 2 3 3 3 3 2 0.94 
45 2 2 3 3 2 3 0.88 
46 2 3 3 3 3 3 1 
47 2 3 3 3 3 3 1 
48 2 3 3 2 3 2 0.88 
49 2 3 2 3 2 3 0.88 
50 2 3 3 3 3 3 1 
51 2 3 3 3 3 2 0.94 
52 2 3 3 2 3 3 0.94 
53 2 3 3 3 3 3 1 
54 2 3 3 2 3 3 0.94 
55 2 3 2 3 3 3 0.94 
56 2 3 3 3 2 3 0.94 
54 2 3 3 2 3 3 0.94 
58 2 3 3 2 3 3 0.94 
59 2 3 3 3 3 2 0.94 
60 2 3 3 2 3 3 0.94 
61 2 3 2 3 3 3 0.94 
62 2 3 3 3 3 2 0.94 
63 2 2 3 3 3 3 0.94 
64 2 3 3 3 2 3 0.94 
65 2 3 3 2 3 3 0.94 
66 2 3 3 2 3 3 0.94 
67 2 3 3 3 3 2 0.94 
68 2 2 3 3 3 3 0.94 
69 2 3 2 3 3 3 0.94 
70 2 3 3 3 2 3 0.94 
71 2 3 3 2 3 3 0.94 
72 2 2 3 2 3 3 0.88 
73 2 3 3 3 3 2 0.94 
74 2 3 3 3 3 3 1 
75 2 3 3 3 2 3 0.94 
76 2 3 2 3 3 3 0.94 
77 2 2 3 3 3 3 0.94 
78 2 2 3 2 3 3 0.88 
79 2 3 3 3 2 3 0.94 
80 2 3 3 2 3 3 0.94 
81 2 3 3 3 3 2 0.94 
82 2 2 3 3 3 3 0.94 
83 2 3 3 3 3 3 1 
84 2 3 3 3 3 2 0.94 
85 2 3 3 2 3 3 0.94 
86 2 3 3 3 2 3 0.94 
87 2 3 3 2 3 3 0.94 
88 2 3 2 3 3 3 0.94 
89 2 3 3 3 3 2 0.94 
90 2 3 3 3 3 3 1 
91 2 2 3 3 3 3 0.94 
92 2 3 3 3 2 3 0.94 
93 2 3 3 3 3 3 1 
94 2 3 3 3 3 3 1 
95 2 3 3 3 3 2 0.94 
96 2 3 3 3 3 3 1 
97 2 2 3 2 3 3 0.88 
98 2 3 2 3 3 3 0.94 
99 2 3 3 3 3 3 1 
100 2 3 3 3 3 3 1 
 
